Implementing TomoTherapy® Technologies in Clinical Practice: Insights from 14 Years of Experience

June 25, 2026
8am EDT | 2pm CEST | 8pm HKT

CE Accreditation Statement

This webinar is approved for 1 Category A Continuing Education Credit by ASRT, CPE Point for Singapore Society of Radiographers & 1 CPD Credit for Hong Kong Radiographers Board. (additional CE’s coming soon!)

This webinar explores the 14-year journey of integrating the TomoTherapy® System into clinical workflows. From the first Hi-Art system in Thailand in 2012 to the Radixact® X9 System with kVCT and real-time tracking. It highlights the progression from basic to advanced techniques (e.g., CSI, head & neck, pelvis, breast, brain/SRS, lung, prostate, ART, TSI/TBI), key clinical/technical challenges, and practical solutions to optimize treatment planning, delivery, imaging, and quality assurance.

Three Key Learning Objectives:

1. Trace the Technological Evolution: Understand the transition from the early TomoTherapy System
to the latest Radixact System, including the integration of kVCT imaging and tracking
technologies.

2. Describe stepwise implementation strategies for introducing TomoTherapy workflows from
basic to advanced clinical indications (CSI, H&N, pelvis, breast, brain/SRS, lung, TSI/TBI, ART).

3. Explain technology evolution and its impact on efficiency and safety, including
improvements in imaging time (MVCT to kVCT), beam-on time, treatment planning speed
(VOLO™ Ultra), delivery verification, and adaptive radiotherapy (PreciseART®).

Presenter: Wannapha Nobnop, Ph.D.

Assistant Professor Division of Radiation Oncology, Department of Radiology, Faculty of Medicine, Chiang Mai University

Chiang Mai University Hospital, Chiang Mai, Thailand

 

Asst. Prof. Dr. Wannapha Nobnop is a medical physicist at the Division of Radiation Oncology, Department of Radiology, Faculty of Medicine, Chiang Mai University, Thailand, and Director of the Master of Science Program in Medical Physics, Chiang Mai University. Research expertise centers on the clinical implementation of advanced radiotherapy, with a strong emphasis on helical TomoTherapy technologies to improve treatment accuracy, patient safety, and clinical efficiency. 

Key areas include TomoTherapy treatment planning optimization and dosimetric evaluation, particularly for breast cancer radiotherapy, focusing on plan efficiency improvement, dose spillage control, and motion-related skin dose assessment. Additional expertise covers adaptive radiotherapy (ART) for head and neck cancer, especially nasopharyngeal carcinoma, including daily dose recalculation, dose accumulation, and deformable image registration, supported by TomoTherapy imaging workflows. 

Research also contributes to IGRT dose calculation accuracy by comparing CBCT, MVCT, and kVCT modalities, and supports development of comprehensive radiotherapy quality assurance (QA) systems, including workflow digitalization, incident reporting, and delivery QA tolerance/action limits aligned with international recommendations. Service includes membership on the Editorial Board / Physics Advisory Editors of Medical Dosimetry (Elsevier B.V.) and affiliation with the American Association of Medical Dosimetrists (AAMD).

Moderator: Lee C. Goddard, Ph.D. 

Assistant Professor, Department of Radiation Oncology at Montefiore Medical Center and Albert Einstein College of Medicine

Montefiore Medical Center, Bronx, New York City, USA

 

Dr. Goddard has deep expertise in TomoTherapy and the Radixact platform, with over a decade of experience advancing high-precision, image-guided radiotherapy and optimizing helical treatment delivery.

He is particularly recognized for his leadership in Synchrony® real-time motion management, helping implement and validate workflows that enable continuous tracking and correction of intrafraction motion during SBRT. His research has demonstrated how adaptive motion management with Radixact can improve dose accuracy and maintain target coverage in moving targets.
 
Dr. Goddard has authored multiple peer-reviewed publications in motion management, SBRT, and dosimetric accuracy, reflecting a growing research impact in this field. He is also active in professional education and collaborative research, frequently presenting on advanced treatment technologies and clinical implementation.
 
He is widely regarded as an emerging thought leader advancing the clinical adoption of real-time adaptive radiotherapy, particularly for motion-managed treatments on the Radixact system.